Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2024
AMBRA1 controls the translation of immune-specific genes in T lymphocytesSimone Gottlieb, Wanjing Shang, Deji Ye, et al.
Modern Rheumatology|March 16, 2026
Effectiveness and Safety of Sarilumab in Polymyalgia Rheumatica: a retrospective study of the FIRST RegistryNaoaki Ohkubo, Yusuke Miyazaki, Satoshi Kubo, et al.
Rheumatology and Therapy|March 2, 2025
Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST RegistryRyuichiro Kanda, Yusuke Miyazaki, Shingo Nakayamada, et al.
Modern Rheumatology|October 23, 2024
The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitisMasatoshi Kanda, Ken Nagahata, Masafumi Moriyama, et al.
Autoimmunity Reviews|September 15, 2019
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"Vanessa Smith, Amber Vanhaecke, Ariane L Herrick, et al.
RMD Open|September 8, 2025
Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case-control analysis on behalf of the EULAR study group on microcirculation in rheumatic diseasesFrancesca Ingegnoli, Nicola Ughi, Valeria Riccieri, et al.
Joint Bone Spine|December 2, 2023
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studiesKim Lauper, Denis Mongin, Sytske Anne Bergstra, et al.
Rheumatology (Oxford, England)|November 7, 2023
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational studyKoshiro Sonomoto, Shingo Nakayamada, Yoshihisa Fujino, et al.
Rheumatology (Oxford, England)|August 19, 2020
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registriesDelphine S Courvoisier, Katarina Chatzidionysiou, Denis Mongin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2026
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational studyTakafumi Aritomi, Koshiro Sonomoto, Shingo Nakayamada, et al.
Pageof 19